Annual CFO
-$19.02 M
+$4.07 M+17.64%
31 December 2023
Summary:
Imunon annual cash flow from operations is currently -$19.02 million, with the most recent change of +$4.07 million (+17.64%) on 31 December 2023. During the last 3 years, it has fallen by -$3.40 million (-21.79%). IMNN annual CFO is now -933.83% below its all-time high of $2.28 million, reached on 01 December 2008.IMNN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$4.06 M
+$449.10 K+9.97%
30 September 2024
Summary:
Imunon quarterly cash flow from operations is currently -$4.06 million, with the most recent change of +$449.10 thousand (+9.97%) on 30 September 2024. Over the past year, it has increased by +$417.60 thousand (+9.34%). IMNN quarterly CFO is now -135.97% below its all-time high of $11.27 million, reached on 01 June 2008.IMNN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$18.21 M
+$417.60 K+2.24%
30 September 2024
Summary:
Imunon TTM cash flow from operations is currently -$18.21 million, with the most recent change of +$417.60 thousand (+2.24%) on 30 September 2024. Over the past year, it has increased by +$2.05 million (+10.13%). IMNN TTM CFO is now -631.79% below its all-time high of $3.42 million, reached on 01 March 2009.IMNN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMNN Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +17.6% | +9.3% | +10.1% |
3 y3 years | -21.8% | -7.1% | -22.5% |
5 y5 years | -170.1% | +9.5% | -112.8% |
IMNN Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -21.8% | +17.6% | -7.5% | +49.2% | -22.5% | +21.4% |
5 y | 5 years | -170.1% | +17.6% | -55.2% | +49.2% | -112.8% | +21.4% |
alltime | all time | -933.8% | +17.6% | -136.0% | +49.2% | -631.8% | +24.4% |
Imunon Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$4.06 M(-10.0%) | -$18.21 M(-2.2%) |
June 2024 | - | -$4.50 M(-23.3%) | -$18.62 M(-10.9%) |
Mar 2024 | - | -$5.87 M(+55.7%) | -$20.91 M(+9.9%) |
Dec 2023 | -$19.02 M(-17.6%) | -$3.77 M(-15.7%) | -$19.02 M(-6.1%) |
Sept 2023 | - | -$4.47 M(-34.2%) | -$20.26 M(-0.8%) |
June 2023 | - | -$6.79 M(+70.6%) | -$20.42 M(+6.9%) |
Mar 2023 | - | -$3.98 M(-20.5%) | -$19.10 M(-17.3%) |
Dec 2022 | -$23.10 M(+42.4%) | -$5.01 M(+7.9%) | -$23.10 M(-0.3%) |
Sept 2022 | - | -$4.64 M(-15.2%) | -$23.18 M(+3.8%) |
June 2022 | - | -$5.47 M(-31.4%) | -$22.32 M(+14.7%) |
Mar 2022 | - | -$7.98 M(+56.8%) | -$19.46 M(+20.0%) |
Dec 2021 | -$16.22 M(+3.9%) | - | - |
Dec 2021 | - | -$5.09 M(+34.4%) | -$16.22 M(+9.1%) |
Sept 2021 | - | -$3.79 M(+44.9%) | -$14.87 M(-1.2%) |
June 2021 | - | -$2.61 M(-44.8%) | -$15.04 M(-2.2%) |
Mar 2021 | - | -$4.74 M(+26.9%) | -$15.38 M(-1.5%) |
Dec 2020 | -$15.62 M(-22.9%) | -$3.73 M(-5.9%) | -$15.62 M(-10.8%) |
Sept 2020 | - | -$3.96 M(+34.4%) | -$17.50 M(-2.9%) |
June 2020 | - | -$2.95 M(-40.7%) | -$18.02 M(-8.5%) |
Mar 2020 | - | -$4.98 M(-11.4%) | -$19.70 M(-2.8%) |
Dec 2019 | -$20.26 M(+187.7%) | -$5.62 M(+25.4%) | -$20.26 M(+136.8%) |
Sept 2019 | - | -$4.48 M(-3.1%) | -$8.56 M(+2.6%) |
June 2019 | - | -$4.63 M(-16.4%) | -$8.34 M(+5.3%) |
Mar 2019 | - | -$5.54 M(-191.0%) | -$7.92 M(+12.5%) |
Dec 2018 | -$7.04 M(-57.7%) | $6.09 M(-242.7%) | -$7.04 M(-59.4%) |
Sept 2018 | - | -$4.27 M(+1.4%) | -$17.34 M(-4.6%) |
June 2018 | - | -$4.21 M(-9.6%) | -$18.18 M(+0.1%) |
Mar 2018 | - | -$4.66 M(+10.6%) | -$18.17 M(+9.2%) |
Dec 2017 | -$16.64 M(-9.5%) | -$4.21 M(-17.6%) | -$16.64 M(-2.7%) |
Sept 2017 | - | -$5.11 M(+21.7%) | -$17.10 M(+2.3%) |
June 2017 | - | -$4.20 M(+34.1%) | -$16.71 M(-0.3%) |
Mar 2017 | - | -$3.13 M(-32.9%) | -$16.77 M(-8.8%) |
Dec 2016 | -$18.38 M(-11.8%) | -$4.66 M(-1.3%) | -$18.38 M(+4.3%) |
Sept 2016 | - | -$4.72 M(+11.1%) | -$17.62 M(-3.3%) |
June 2016 | - | -$4.25 M(-10.4%) | -$18.21 M(-7.3%) |
Mar 2016 | - | -$4.74 M(+21.7%) | -$19.64 M(-5.7%) |
Dec 2015 | -$20.83 M(-2.4%) | -$3.90 M(-26.7%) | -$20.83 M(-11.1%) |
Sept 2015 | - | -$5.32 M(-6.2%) | -$23.44 M(-2.2%) |
June 2015 | - | -$5.67 M(-4.4%) | -$23.96 M(+6.6%) |
Mar 2015 | - | -$5.94 M(-8.8%) | -$22.47 M(+5.2%) |
Dec 2014 | -$21.35 M(+124.2%) | -$6.51 M(+11.5%) | -$21.35 M(+16.6%) |
Sept 2014 | - | -$5.84 M(+39.5%) | -$18.31 M(+21.0%) |
June 2014 | - | -$4.18 M(-13.3%) | -$15.13 M(-6.2%) |
Mar 2014 | - | -$4.82 M(+39.1%) | -$16.14 M(+69.4%) |
Dec 2013 | -$9.53 M(-57.0%) | -$3.47 M(+30.2%) | -$9.53 M(-20.9%) |
Sept 2013 | - | -$2.66 M(-48.7%) | -$12.04 M(-17.7%) |
June 2013 | - | -$5.19 M(-389.8%) | -$14.63 M(+0.0%) |
Mar 2013 | - | $1.79 M(-129.9%) | -$14.63 M(-34.0%) |
Dec 2012 | -$22.14 M(-2.6%) | -$5.98 M(+13.8%) | -$22.14 M(+7.5%) |
Sept 2012 | - | -$5.25 M(+1.4%) | -$20.61 M(-7.4%) |
June 2012 | - | -$5.18 M(-9.5%) | -$22.26 M(-7.6%) |
Mar 2012 | - | -$5.73 M(+29.0%) | -$24.10 M(+6.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | -$22.74 M(+70.1%) | -$4.44 M(-35.7%) | -$22.74 M(+7.9%) |
Sept 2011 | - | -$6.91 M(-1.7%) | -$21.07 M(+17.4%) |
June 2011 | - | -$7.03 M(+60.7%) | -$17.95 M(+22.1%) |
Mar 2011 | - | -$4.37 M(+57.7%) | -$14.71 M(+10.0%) |
Dec 2010 | -$13.37 M(+1336.9%) | -$2.77 M(-26.8%) | -$13.37 M(-5.7%) |
Sept 2010 | - | -$3.78 M(+0.1%) | -$14.18 M(-8.2%) |
June 2010 | - | -$3.78 M(+24.7%) | -$15.45 M(+1631.7%) |
Mar 2010 | - | -$3.03 M(-15.4%) | -$892.30 K(-4.1%) |
Dec 2009 | -$930.30 K(-140.8%) | -$3.58 M(-29.1%) | -$930.40 K(-170.3%) |
Sept 2009 | - | -$5.06 M(-146.9%) | $1.32 M(-54.8%) |
June 2009 | - | $10.78 M(-451.2%) | $2.93 M(-14.4%) |
Mar 2009 | - | -$3.07 M(+130.6%) | $3.42 M(+50.1%) |
Dec 2008 | $2.28 M(-123.8%) | -$1.33 M(-61.4%) | $2.28 M(+111.8%) |
Sept 2008 | - | -$3.45 M(-130.6%) | $1.08 M(-281.5%) |
June 2008 | - | $11.27 M(-367.7%) | -$593.40 K(-95.7%) |
Mar 2008 | - | -$4.21 M(+66.2%) | -$13.95 M(+45.5%) |
Dec 2007 | -$9.58 M(+32.5%) | -$2.53 M(-50.5%) | -$9.58 M(+17.8%) |
Sept 2007 | - | -$5.12 M(+146.3%) | -$8.14 M(+65.1%) |
June 2007 | - | -$2.08 M(-1465.3%) | -$4.93 M(-19.5%) |
Mar 2007 | - | $152.30 K(-114.0%) | -$6.12 M(-15.3%) |
Dec 2006 | -$7.23 M(-10.3%) | -$1.09 M(-43.1%) | -$7.23 M(+2.5%) |
Sept 2006 | - | -$1.91 M(-41.6%) | -$7.06 M(-1.6%) |
June 2006 | - | -$3.28 M(+242.7%) | -$7.17 M(+17.4%) |
Mar 2006 | - | -$956.00 K(+4.6%) | -$6.11 M(-24.3%) |
Dec 2005 | -$8.06 M(-42.2%) | -$913.60 K(-54.9%) | -$8.06 M(-23.8%) |
Sept 2005 | - | -$2.03 M(-8.4%) | -$10.59 M(-14.3%) |
June 2005 | - | -$2.21 M(-24.1%) | -$12.35 M(-13.7%) |
Mar 2005 | - | -$2.91 M(-15.3%) | -$14.31 M(+2.7%) |
Dec 2004 | -$13.94 M(+53.4%) | -$3.44 M(-9.3%) | -$13.94 M(+5.1%) |
Sept 2004 | - | -$3.79 M(-9.2%) | -$13.26 M(+8.0%) |
June 2004 | - | -$4.17 M(+64.4%) | -$12.28 M(+21.9%) |
Mar 2004 | - | -$2.54 M(-7.9%) | -$10.07 M(+1.1%) |
Dec 2003 | - | -$2.76 M(-1.6%) | -$9.97 M(+9.7%) |
Sept 2003 | -$9.09 M(-0.3%) | -$2.80 M(+42.2%) | -$9.09 M(+7.7%) |
June 2003 | - | -$1.97 M(-19.0%) | -$8.44 M(-5.1%) |
Mar 2003 | - | -$2.43 M(+29.4%) | -$8.89 M(-2.4%) |
Dec 2002 | - | -$1.88 M(-12.5%) | -$9.11 M(-0.1%) |
Sept 2002 | -$9.11 M(+46.4%) | -$2.15 M(-11.3%) | -$9.11 M(+2.4%) |
June 2002 | - | -$2.42 M(-8.6%) | -$8.90 M(+10.8%) |
Mar 2002 | - | -$2.65 M(+40.6%) | -$8.03 M(+17.6%) |
Dec 2001 | - | -$1.89 M(-2.8%) | -$6.83 M(+9.7%) |
Sept 2001 | -$6.22 M(+61.0%) | -$1.94 M(+24.7%) | -$6.22 M(+25.0%) |
June 2001 | - | -$1.56 M(+7.4%) | -$4.98 M(+9.4%) |
Mar 2001 | - | -$1.45 M(+13.2%) | -$4.55 M(+15.3%) |
Dec 2000 | - | -$1.28 M(+83.9%) | -$3.95 M(+2.1%) |
Sept 2000 | -$3.87 M(+68.1%) | -$695.90 K(-38.2%) | -$3.87 M(+21.9%) |
June 2000 | - | -$1.13 M(+33.3%) | -$3.17 M(+55.1%) |
Mar 2000 | - | -$844.60 K(-29.6%) | -$2.04 M(+70.4%) |
Dec 1999 | - | -$1.20 M | -$1.20 M |
Sept 1999 | -$2.30 M(+8.9%) | - | - |
Sept 1998 | -$2.11 M(+82.9%) | - | - |
Sept 1997 | -$1.15 M(-21.0%) | - | - |
Sept 1996 | -$1.46 M | - | - |
FAQ
- What is Imunon annual cash flow from operations?
- What is the all time high annual CFO for Imunon?
- What is Imunon annual CFO year-on-year change?
- What is Imunon quarterly cash flow from operations?
- What is the all time high quarterly CFO for Imunon?
- What is Imunon quarterly CFO year-on-year change?
- What is Imunon TTM cash flow from operations?
- What is the all time high TTM CFO for Imunon?
- What is Imunon TTM CFO year-on-year change?
What is Imunon annual cash flow from operations?
The current annual CFO of IMNN is -$19.02 M
What is the all time high annual CFO for Imunon?
Imunon all-time high annual cash flow from operations is $2.28 M
What is Imunon annual CFO year-on-year change?
Over the past year, IMNN annual cash flow from operations has changed by +$4.07 M (+17.64%)
What is Imunon quarterly cash flow from operations?
The current quarterly CFO of IMNN is -$4.06 M
What is the all time high quarterly CFO for Imunon?
Imunon all-time high quarterly cash flow from operations is $11.27 M
What is Imunon quarterly CFO year-on-year change?
Over the past year, IMNN quarterly cash flow from operations has changed by +$417.60 K (+9.34%)
What is Imunon TTM cash flow from operations?
The current TTM CFO of IMNN is -$18.21 M
What is the all time high TTM CFO for Imunon?
Imunon all-time high TTM cash flow from operations is $3.42 M
What is Imunon TTM CFO year-on-year change?
Over the past year, IMNN TTM cash flow from operations has changed by +$2.05 M (+10.13%)